MRC Technology (MRCT) and the University of Turku (UTU, Finland) have signed a memorandum of understanding outlining how they will work together to translate biological and medical research from UTU into new therapeutics and diagnostics. UTU researchers have considerable expertise in molecular biosciences, cardiovascular and metabolic research, with particular strengths in diagnostic development and antibody technologies. UTU’s research expertise shares synergy with MRCT’s collaborative diagnostic and therapeutic discovery programmes, which help progress early-stage academic projects towards the clinic. Through this agreement, MRCT and UTU aim to combine their capabilities to move promising medical research forward into viable and accessible diagnostics and patient treatments.